Skinvisible

Skinvisible Intangible Assets

The Intangible Assets of Skinvisible (SKVI) as of Oct 20, 2026 is 116,200.00 USD. In the previous year, Intangible Assets was 127,400.00 USD — a change of -8.79% (lower).

Intangible Assets

116,200.00USD

YoY

-8.79%

Last updated:

Intangible Assets of Skinvisible is 2024 116,200.00 USD. Intangible Assets of Skinvisible was 2023 127,400.00 USD. It decreases by -8.79% lower compared to the previous year.

The Skinvisible Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
206,000.00 USD
Jan 1, 2018
178,800.00 USD
Jan 1, 2019
165,400.00 USD
Jan 1, 2020
150,100.00 USD
Jan 1, 2021
153,100.00 USD
Jan 1, 2022
136,900.00 USD
Jan 1, 2023
127,400.00 USD
Jan 1, 2024
116,200.00 USD
The Skinvisible Intangible Assets history
YEARIntangible AssetsYoY
116,200.00USD-8.79%
127,400.00USD-6.94%
136,900.00USD-10.58%
153,100.00USD+2.00%
150,100.00USD-9.25%
165,400.00USD-7.49%
178,800.00USD-13.20%
206,000.00USD-15.95%
245,100.00USD-18.76%
301,700.00USD-14.39%
352,400.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Skinvisible Stock analysis

What does Skinvisible do? Skinvisible Inc develops and patents the Invisicare polymer delivery system, which enhances the delivery of active ingredients in topical skin care products. The company has formulated over forty topical skin products using Invisicare, with Pivotal being the patented technology that enables extended duration of active ingredients on the skin. Invisicare specifically carries water-insoluble and certain cationic active ingredients in water-based products without alcohol, silicones, waxes, or organic solvents. The firm's revenue comes from licensing the Invisicare technology to partners who develop and sell skin care products incorporating this delivery system. Skinvisible Inc's primary customers are pharmaceutical and cosmetic companies seeking to improve the efficacy of their topical skin care formulations. These companies purchase the Invisicare technology to integrate into their own product lines, leveraging the extended delivery duration and compatibility with water-based formulations. The company does not sell end-user products but focuses on technology licensing for partners who manufacture and market the final skin care products. The business model relies on the patent protection of Invisicare, which allows Skinvisible to generate revenue through licensing agreements. Partners pay for the right to use the technology in their products, with the company's focus on developing and protecting the polymer delivery system as its core asset. The firm's product portfolio includes over forty topical skin products developed using Invisicare, but these are not sold directly by Skinvisible Inc. Skinvisible is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Skinvisible stock

Intangible Assets of Skinvisible is 116,200.00 USD in 2024.

Intangible Assets of Skinvisible changed from 127,400.00 USD to 116,200.00 USD, representing a -8.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Skinvisible since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Skinvisible historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Skinvisible

All Key Metrics — Skinvisible